{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:05:22Z","timestamp":1791165922396,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["268868"],"award-info":[{"award-number":["268868"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["311122"],"award-info":[{"award-number":["311122"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["257786"],"award-info":[{"award-number":["257786"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jconrel.2018.05.034","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T07:21:18Z","timestamp":1527751278000},"page":"261-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Melanin targeting for intracellular drug delivery: Quantification of bound and free drug in retinal pigment epithelial cells"],"prefix":"10.1016","volume":"283","author":[{"given":"Anna-Kaisa","family":"Rimpel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Kidron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6064-3102","authenticated-orcid":false,"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.05.034_bb0005","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3109\/03602538409033561","article-title":"The melanin binding of drugs and its implications","volume":"15","author":"Ings","year":"1984","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0749.1993.tb00591.x","article-title":"Interaction between chemicals and melanin","volume":"6","author":"Larsson","year":"1993","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/rtph.1998.1243","article-title":"Binding of drugs to eye melanin is not predictive of ocular toxicity","volume":"28","author":"Leblanc","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0025","first-page":"467","article-title":"Melanin content of hamster tissues, human tissues, and various melanomas","volume":"41","author":"Watts","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejps.2017.07.027","article-title":"Melanin binding study of clinical drugs with cassette dosing and rapid equilibrium dialysis inserts","volume":"109","author":"Pelkonen","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-4835(84)90104-0","article-title":"Disposition of ophthalmic timolol in treated and untreated rabbit eyes. A multiple and single dose study","volume":"38","author":"Salminen","year":"1984","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0378-5173(84)90103-0","article-title":"Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. I. Drug distribution and metabolism","volume":"18","author":"Salminen","year":"1984","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-5173(84)90132-7","article-title":"Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. II. Drug response","volume":"19","author":"Urtti","year":"1984","journal-title":"Int. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0050","first-page":"19","article-title":"Chapter II: melanin affinity of chloroquine and chlorpromazine examined by whole body autoradiography","volume":"14","author":"Lindquist","year":"1973","journal-title":"Acta Radiol."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0055","first-page":"1158","article-title":"Chloroquine retinopathy in the rhesus monkey","volume":"17","author":"Rosenthal","year":"1978","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0060","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1167\/iovs.12-10169","article-title":"Assessing a novel depot delivery strategy for noninvasive administration of VEGF\/PDGF RTK inhibitors for ocular neovascular disease","volume":"54","author":"Robbie","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0065","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/mp4000822","article-title":"Rapid measurement of intracellular unbound drug concentrations","volume":"10","author":"Mateus","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0070","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1021\/jm401963n","article-title":"A high-throughput cell-based method to predict the unbound drug fraction in the brain","volume":"57","author":"Mateus","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0075","doi-asserted-by":"crossref","first-page":"E6231","DOI":"10.1073\/pnas.1701848114","article-title":"Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery","volume":"114","author":"Mateus","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0080","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0085","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.5b00787","article-title":"Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics, and single photon emission computed tomography\/computed tomography imaging","volume":"13","author":"Rimpel\u00e4","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/srep43047","article-title":"Intracellular drug bioavailability: a new predictor of system dependent drug disposition","volume":"7","author":"Mateus","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0095","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acs.molpharmaceut.5b00783","article-title":"Interpretation of ocular melanin drug binding assays. Alternatives to the model of multiple classes of independent sites","volume":"13","author":"Manzanares","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0100","first-page":"195","article-title":"Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells","volume":"25","author":"Feeney-Burns","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0105","author":"EMBL-EBI, ChEMBL"},{"key":"10.1016\/j.jconrel.2018.05.034_bb0110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.21569","article-title":"Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance\u2013associated protein 1 and provokes high levels of cross-resistance to glucocorticoids","volume":"54","author":"Oerlemans","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0115","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0006-2952(98)00217-2","article-title":"Direct binding of chloroquine to the multidrug resistance protein (MRP): possible role for MRP in chloroquine drug transport and resistance in tumor cells","volume":"56","author":"Vezmar","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0120","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s11095-009-9890-6","article-title":"Efflux protein expression in human retinal pigment epithelium cell lines","volume":"26","author":"Mannermaa","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0125","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1124\/dmd.112.046599","article-title":"Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics","volume":"40","author":"Nagar","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0130","first-page":"822","article-title":"Affinity of ocular acid-insoluble melanin for drugs in vitro","volume":"28","author":"Tsuchiya","year":"1987","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0135","first-page":"229","article-title":"Binding of chlorpromazine to cultured retinal pigment epithelial cells loaded with melanin","volume":"6","author":"Basu","year":"1989","journal-title":"Lens Eye Toxic. Res."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/acs.molpharmaceut.6b00782","article-title":"LC-MS\/MS based quantitation of ABC and SLC transporter proteins in plasma membranes of cultured primary human retinal pigment epithelium cells and immortalized ARPE19 cell line","volume":"14","author":"Pelkonen","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.034_bb0145","first-page":"622","article-title":"Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating","volume":"20","author":"Sorkio","year":"2014","journal-title":"Tissue Eng. Part A"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918303183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918303183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:36:44Z","timestamp":1759160204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918303183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"alternative-id":["S0168365918303183"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.034","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanin targeting for intracellular drug delivery: Quantification of bound and free drug in retinal pigment epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}